FY2025 EPS Estimates for ADCT Raised by Cantor Fitzgerald

ADC Therapeutics SA (NYSE:ADCT – Free Report) – Cantor Fitzgerald increased their FY2025 earnings per share estimates for ADC Therapeutics in a report released on Wednesday, August 13th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the company will post earnings per share of ($1.73) for the year, up from their prior estimate of ($1.91). […]

Leave a Reply

Your email address will not be published.

Previous post Roth Capital Forecasts Higher Earnings for Prairie Operating
Next post Equities Analysts Issue Forecasts for AJG FY2025 Earnings